Pharma Is Out of Favor. 5 Drug Stocks With Room to Grow.

Despite Eli Lilly's monster 66.8% gain on the year because of weight-loss drugs, the S&P 500 Pharmaceuticals index is down 2.3%.

Related Keywords

Bristol Myers Squibb ,Pfizer ,Eli Lilly ,Johnson ,Pearl River ,Article Normal ,Pharmaceuticals ,Machinery ,Agricultural Machinery ,Healthcare Life Sciences ,Industrial Goods ,Financial Performance ,Earnings ,Corporate Industrial News ,Political General News ,Physical Mental Fitness ,Health ,Living Lifestyle ,Weight Management ,Content Types ,Factiva Filters ,C Amp Ampe Industry News Filter ,Synd ,Barron Amp 39s Stock Screen ,Biotech And Pharma ,Healthcare ,Markets ,North America ,Johnson Amp ,Jnj ,Bmy ,Viatris ,Vtrs ,Astrazeneca ,Azn Ln ,Azn ,Novo Nordisk ,Novob Ko ,Nvo ,Eli Lilly Amp ,Rally ,Pfe ,Zoetis ,Zts ,Vaneck Pharmaceutical Etf ,Apph ,Corporate ,Industrial News ,Political ,General News ,Physical ,Mental Fitness ,Living ,Lifestyle ,Life Sciences ,